scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00127-007-0204-1 |
P698 | PubMed publication ID | 17516013 |
P2093 | author name string | Martin Härter | |
Harald Baumeister | |||
P2860 | cites work | Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project | Q22242341 |
Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies | Q22252218 | ||
Prevalence, Severity, and Unmet Need for Treatment of Mental Disorders in the World Health Organization World Mental Health Surveys | Q22252996 | ||
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication | Q22253031 | ||
Distinguishing between the validity and utility of psychiatric diagnoses | Q28198403 | ||
Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey | Q28258215 | ||
Prevalence and treatment of mental disorders, 1990 to 2003 | Q33760833 | ||
Subthreshold disorders in psychiatry: clinical reality, methodological artifact, and the double-threshold problem | Q33881088 | ||
Psychiatric epidemiology: selected recent advances and future directions | Q33961039 | ||
Psychiatric epidemiology | Q34023637 | ||
Schizophrenia and related disorders: experience with current diagnostic systems. | Q34141643 | ||
The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. | Q34209498 | ||
Diagnostic Criteria for Use in Psychiatric Research | Q34226390 | ||
A diagnostic interview: the schedule for affective disorders and schizophrenia | Q34269355 | ||
The National Comorbidity Survey Replication (NCS-R): background and aims. | Q34339246 | ||
The US National Comorbidity Survey Replication (NCS-R): design and field procedures. | Q34339251 | ||
Depressive disorders in Europe: prevalence figures from the ODIN study | Q34518032 | ||
Somatic symptom index (SSI): a new and abridged somatization construct. Prevalence and epidemiological correlates in two large community samples | Q34561627 | ||
Psychiatric epidemiology: it's not just about counting anymore | Q35062093 | ||
Subthreshold depression as a risk indicator for major depressive disorder: a systematic review of prospective studies | Q35720897 | ||
Somatoform disorders: time for a new approach in DSM-V. | Q36111638 | ||
SCAN. Schedules for Clinical Assessment in Neuropsychiatry | Q37929723 | ||
Psychiatric epidemiology in Korea. Part I: Gender and age differences in Seoul. | Q39266997 | ||
Prevalence of psychiatric disorders in Taiwan defined by the Chinese Diagnostic Interview Schedule | Q39286113 | ||
Mental health supplement to the Ontario Health Survey: methodology | Q39437049 | ||
The National Psychiatric Morbidity surveys of Great Britain--initial findings from the household survey. | Q39449886 | ||
Lifetime prevalence of DSM-III-R psychiatric disorders among urban and rural Mexican Americans in California | Q39475228 | ||
The 12-month prevalence and risk factors for major depressive episode in Finland: representative sample of 5993 adults | Q39548327 | ||
Epidemiologic differences in drug dependence--a US-UK cross-national comparison | Q39645463 | ||
Prevalence, service use, and demographic correlates of 12-month DSM-IV psychiatric disorders in Mexico: results from the Mexican National Comorbidity Survey | Q39737071 | ||
Twelve-month prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China. | Q39738515 | ||
Mild Disorders Should Not Be Eliminated From the DSM-V | Q40550519 | ||
Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review | Q40691529 | ||
Prevalence of mental disorders and psychosocial impairments in adolescents and young adults | Q40868504 | ||
The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description | Q41128285 | ||
Epidemiology of mood disorders: a community survey in Florence | Q43438369 | ||
Estimating the prevalence of mental and somatic disorders in the community: aims and methods of the German National Health Interview and Examination Survey. | Q43575449 | ||
A1 Ain Community Psychiatric Survey. I. Prevalence and socio-demographic correlates | Q43587361 | ||
A Norwegian psychiatric epidemiological study | Q43657292 | ||
Prevalence, comorbidity, disability and service utilisation. Overview of the Australian National Mental Health Survey | Q43725589 | ||
Prevalence of ICD-10 mental disorders in a catchment area in the city of São Paulo, Brazil | Q44058747 | ||
Gender differences in depression. Epidemiological findings from the European DEPRES I and II studies | Q44228904 | ||
Lifetime and six-month prevalence of mental disorders in the Munich Follow-Up Study | Q44441471 | ||
Measuring psychiatric disorder in the community: a standardized assessment for use by lay interviewers | Q44519084 | ||
The Sesto Fiorentino study: background, methods and preliminary results. Lifetime prevalence of psychiatric disorders in an Italian community sample using clinical interviewers | Q44631962 | ||
DSM-IV mood-, anxiety- and alcohol use disorders and their comorbidity in the Finnish general population--results from the Health 2000 Study | Q45205458 | ||
Minor depression as a predictor of the first onset of major depressive disorder over a 15-year follow-up | Q45245900 | ||
Social phobia symptoms, subtypes, and severity: findings from a community survey | Q46361769 | ||
An open trial of paroxetine for the "offensive subtype" of taijin kyofusho and social anxiety disorder | Q46926502 | ||
Is taijin kyofusho a culture-bound syndrome? | Q47387998 | ||
12-month prevalence of panic disorder with or without agoraphobia in the Swedish general population | Q47437743 | ||
Mental disorders and medical conditions. A community study in a small island in Spain | Q48699320 | ||
The National Psychiatric Morbidity surveys of Great Britain--strategy and methods | Q50181464 | ||
Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. | Q50766705 | ||
Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS). | Q50852126 | ||
The Netherlands Mental Health Survey and Incidence Study (NEMESIS): objectives and design. | Q50852131 | ||
Outcomes of minor and subsyndromal depression among elderly patients in primary care settings. | Q51919473 | ||
The prevalence of DSM-IV personality disorders in psychiatric outpatients. | Q51925396 | ||
Why DSM-III was right to introduce the concept of somatoform disorders. | Q51932098 | ||
Trends in service use and treatment for mental disorders in adults throughout Great Britain. | Q51936042 | ||
Continued needs for epidemiological studies of mental disorders in the community. | Q51940260 | ||
Prevalence, co-morbidity and correlates of mental disorders in the general population: results from the German Health Interview and Examination Survey (GHS). | Q51941445 | ||
Prevalence of psychiatric disorder and the need for psychiatric care in Northern Ireland. Population study in the District of Derry. | Q51953613 | ||
The 12-month prevalence and characteristics of major depressive episode in a representative nationwide sample of adolescents and young adults. | Q51962384 | ||
Prevalence, incidence and age at onset of psychiatric disorders in Norway. | Q51977860 | ||
Epidemiology of somatoform disorders: a community survey in Florence. | Q52005365 | ||
The prevalence of specific psychiatric disorders in Puerto Rico. | Q52074053 | ||
Design and field methods of the Edmonton survey of psychiatric disorders. | Q52087625 | ||
Renard diagnostic interview. Its reliability and procedural validity with physicians and lay interviewers. | Q52101920 | ||
National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. | Q52101976 | ||
Australia's mental health: an overview of the general population survey | Q73733459 | ||
Somatization symptoms and hypochondriacal features in the general population | Q74311123 | ||
[Lifetime prevalence of mental disorders in general adult population. Results of TACOS study] | Q74318904 | ||
Minor depression: midway between major depression and euthymia | Q83059843 | ||
P433 | issue | 7 | |
P304 | page(s) | 537-546 | |
P577 | publication date | 2007-05-21 | |
P1433 | published in | Social Psychiatry and Psychiatric Epidemiology | Q15760648 |
P1476 | title | Prevalence of mental disorders based on general population surveys | |
P478 | volume | 42 |
Q38977472 | A Systematic Review of Psychiatric and Psychosocial Comorbidities of Genetic Generalised Epilepsies (GGE). |
Q34510610 | Affective disorders among patients with borderline personality disorder |
Q46682262 | Affective, anxiety, and substance-related disorders in patients undergoing herniated disc surgery |
Q48016081 | An Investigation of a Computerized Sequential Depression Module of the MMPI-2. |
Q33663230 | Antidepressant effects of resveratrol in an animal model of depression |
Q93159858 | Association of ADHD symptoms, depression and suicidal behaviors with anxiety in Chinese medical college students |
Q38990848 | Associations between psychosocial problems and personality disorders among Egyptian adolescents |
Q48064974 | Attitudes towards depression, psychiatric medication and help-seeking intentions amid financial crisis: Findings from Athens area |
Q30835175 | Barriers and facilitators of help-seeking among unemployed persons with mental health problems: a qualitative study |
Q37057303 | Birth factors and common mental health problems in young adults: a population-based study in North Staffordshire |
Q38465022 | Brazilian Portuguese version of the Spence Children's Anxiety Scale (SCAS-Brasil). |
Q46309169 | Clinical epidemiology in patients admitted at Mathari Psychiatric Hospital, Nairobi, Kenya |
Q53840066 | Comorbid psychiatric disorders in a clinical sample of adults with ADHD, and associations with education, work and social characteristics: a cross-sectional study. |
Q38323748 | Depression as a risk factor for acute coronary syndrome: a review |
Q44020864 | Depression impacts the course of recovery in patients with acute low-back pain |
Q37004936 | Depression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of life |
Q46162214 | Depressive symptoms in the Belgian population: disentangling age and cohort effects |
Q55234710 | Development of the Spence Children’s Anxiety Scale - Short Version (SCAS-S). |
Q37251828 | Diagnosis and treatment of mood disorders in adults with developmental disabilities |
Q46950718 | Dropout from outpatient mental health care: results from the Israel National Health Survey |
Q34192312 | Gender differences in the relationship of internalizing and externalizing psychopathology to alcohol dependence: likelihood, expression and course |
Q37779253 | Healthcare costs in patients with diabetes mellitus and comorbid mental disorders--a systematic review |
Q41728509 | Higher serum 25-hydroxyvitamin D concentrations are related to a reduced risk of depression |
Q35468949 | Life stress and mental disorders in the South African stress and health study. |
Q36508240 | Long term psychosocial outcomes of congenital heart disease (CHD) in adolescents and young adults |
Q57822927 | Massachusetts Youth Screening Instrument for mental health needs of youths in residential welfare/justice institutions: identifying gender differences across countries and settings |
Q51873697 | Predictors of anxiety symptoms in the gynecological outpatient setting: The Thai experience. |
Q35819892 | Prevalence, associated factors and predictors of anxiety: a community survey in Selangor, Malaysia |
Q38961306 | Prevalence, trends, correlates and treatment of depression in Chile in 2003 to 2010. |
Q24194667 | Prevention of depression in chronically physically ill adults |
Q59147153 | Psychiatric Disorders |
Q44418541 | Psychological comorbidity in patients with musculoskeletal diseases |
Q44134844 | Relationship quality and levels of depression and anxiety in a large population-based survey |
Q38290421 | Relevance of the anti-inflammatory properties of curcumin in neurodegenerative diseases and depression. |
Q50550290 | Reliability and Validity of the Spence Children's Anxiety Scale for Parents in Mainland Chinese Children and Adolescents. |
Q46657224 | Self-reported depression in first-year nursing students in relation to socio-demographic and educational factors: a nationwide cross-sectional study in Sweden |
Q37254701 | Self-reported quality of life and self-esteem in sad and anxious school children |
Q47250462 | Sex differences and the influence of social factors in a Chilean urban psychiatric hospital population. |
Q38663820 | Smartphone-Based Monitoring of Objective and Subjective Data in Affective Disorders: Where Are We and Where Are We Going? Systematic Review |
Q51895993 | Social anxiety disorder above and below the diagnostic threshold: prevalence, comorbidity and impairment in the general population. |
Q36092716 | Substance use disorder and schizophrenia: prevalence and sociodemographic characteristics in the Latin American population |
Q34130842 | Substance use disorder comorbidity with schizophrenia in families of Mexican and Central American ancestry |
Q45787667 | Survey of breast implant patients: characteristics, depression rate, and quality of life |
Q51863862 | The Dresden Predictor Study of anxiety and depression: objectives, design, and methods. |
Q36133298 | The Four-Dimensional Symptom Questionnaire (4DSQ) in the general population: scale structure, reliability, measurement invariance and normative data: a cross-sectional survey |
Q49072395 | The Patient Assessment of Chronic Illness Care questionnaire: evaluation in patients with mental disorders in primary care |
Q47814734 | The Role of Child and Adolescent Adjustment Problems and Sleep Disturbance in Parent Psychological Distress. |
Q47595268 | The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders |
Q37857758 | The prevention of child and adolescent anxiety: a meta-analytic review |
Q88155297 | Treatment course and its predictors in patients with somatoform disorders: A routine outcome monitoring study in secondary psychiatric care |
Q46892915 | Trends in socio-economic differences in self-reported depression during the years 1979-2002 in Finland |
Q92827083 | Variance Components Models for Analysis of Big Family Data of Health Outcomes in the Lifelines Cohort Study |
Search more.